Details for New Drug Application (NDA): 008708
✉ Email this page to a colleague
NDA 008708 describes DIBENZYLINE, which is a drug marketed by Advanz Pharma and is included in one NDA. Additional details are available on the DIBENZYLINE profile page.
The generic ingredient in DIBENZYLINE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
The generic ingredient in DIBENZYLINE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.
Summary for 008708
| Tradename: | DIBENZYLINE |
| Applicant: | Advanz Pharma |
| Ingredient: | phenoxybenzamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008708
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
